Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT2016041627408N1Phase 3Completed
Phase 3 trial of dimeticone and permethrin in pediculosis capitis (3 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Primary efficacy. Started May 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT2016041627408N1.